Home / Learn / Resource Detail

Supportive Oncodermatology: Managing Skin, Hair, and Nail Toxicities in Cancer Care – [Video Podcast] Ep 53

January 22, 2025

 

Adverse reactions involving the skin, nails, and hair are common among patients undergoing treatment for cancer and are often underreported and overlooked. These reactions directly impact patient quality of life and may be the reason for interruptions in lifesaving antineoplastic treatment. To address these toxicities, the Association of Cancer Care Centers (ACCC) is leading an initiative that aims to educate providers and other cancer care team members about the optimal management of dermatologic side effects.  

In this episode, CANCER BUZZ speaks with Julie Ryan Wolf, PhD, MPH and C.J.G. (Corina) van den Hurk, PhD, the chair and vice chair of the Oncodermatology Study Group at the Multinational Association of Supportive Care in Cancer (MASCC) about common oncodermatological toxicities including radiation dermatitis, hair loss, and nail changes unique to EGFR-inhibitors. Also discussed are strategies to increase provider collaboration to intervene at an early stage to improve quality of life for patients receiving cancer treatment.

“If we have symptom monitoring on a regular basis throughout the course of treatment, we’ll be able to intervene sooner… helping improve [patient] quality of life” – Julie Ryan Wolf, PhD, MPH

“In effect, almost each patient has a dermatologic side effect at the end of the treatment, or has experienced that during the treatment, and they are all very interfering.” – CJG (Corina) van den Hurk, PhD

 

/images/podcast/sharman-jeff-circle.png

Julie Ryan Wolf, PhD, MPH  

Chair, Oncodermatology Study Group 

Multinational Association of Supportive Care in Cancer (MASCC) 

Associate Professor, Department of Dermatology, Department of Radiation Oncology  

                                      University of Rochester Medical Center  

                                      Rochester, NY  

 

/images/podcast/sharman-jeff-circle.png

CJG (Corina) van den Hurk, PhD  

Vice Chair, Oncodermatology Study Group 

Multinational Association of Supportive Care in Cancer (MASCC) 

Senior Researcher, Santeon Hospitals  

                                      Netherlands

 

Thank you to Johnson & Johnson for their support of this program.  

 Additional Reading/Sources    

 


The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.